Creative Medical Technology Holdings, Inc. Stock
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.35 USD | -2.63% | +0.93% | -5.64% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 563K | Capitalization | 5.86M |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | -4M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.4 x |
P/E ratio 2024 * |
-1.32
x | P/E ratio 2025 * |
-1.69
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.05% |
1 day | -2.63% | ||
1 week | +0.93% | ||
1 month | -2.03% | ||
3 months | +4.57% | ||
6 months | -2.25% | ||
Current year | -5.64% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 16-05-17 | |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Snow
BRD | Director/Board Member | 67 | 21-12-01 |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Executive Officer | 63 | 16-05-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 4.35 | -2.63% | 2,843 |
24-05-30 | 4.468 | +2.71% | 2,557 |
24-05-29 | 4.35 | -1.14% | 3,690 |
24-05-28 | 4.4 | +2.09% | 2,722 |
24-05-24 | 4.31 | -2.04% | 2,773 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.64% | 5.86M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- CELZ Stock